Vijaya Diagnostic Centre Q1 FY27 Net Profit Surges 37.6% to 531 Million Rupees

Nikunj Parikh - Mumbai Bureau Aug 06, 2026 1,100 Views

Vijaya Diagnostic Centre Limited reported a 37.6% year-on-year increase in net profit to 531 million rupees for Q1 FY27. Revenue from operations grew 22.8% to 2.31 billion rupees, driven by a 16.5% rise in diagnostic test volumes and ongoing geographic network expansion.

HYDERABAD — Vijaya Diagnostic Centre Limited reported a 37.6% year-on-year increase in consolidated profit after tax to 531 million rupees (INR 53.10 crore) for the first quarter ended June 30, 2026, supported by robust volume expansion and higher patient realization across its footprint.

The Hyderabad-headquartered integrated diagnostic chain recorded consolidated revenue from operations of 2.31 billion rupees (INR 230.98 crore) for Q1 FY27, up 22.8% from 1.88 billion rupees reported in the corresponding period of the previous fiscal year. The performance registered positive momentum despite the first quarter historically representing a moderate season for the diagnostic sector.

Operating Performance and Margin Expansion

Vijaya Diagnostic Centre demonstrated operating leverage, with EBITDA rising 34.0% year-on-year to 985.4 million rupees in Q1 FY27 from 735.3 million rupees in Q1 FY26. The company's EBITDA margin expanded by 356 basis points to 42.7%. Consolidated profit after tax margin improved by 247 basis points to 23.0%, compared to 20.5% in the same quarter last year.

Operational Metrics Summary

Total Diagnostic Tests: Reached 4.59 million, marking a 16.5% year-on-year growth compared to 3.94 million tests conducted in Q1 FY26.
Total Patient Footfall: Expanded 12.7% to 1.24 million, up from 1.10 million in the prior-year period.
Tests per Footfall: Rose to 3.70 from 3.58.
Average Realization: Realization per test grew 5.5% to INR 503, while average realization per footfall increased 9.0% to INR 1,860.
Wellness Share: Wellness tests accounted for 14.8% of total revenue, rising 56 basis points year-on-year.

Network Infrastructure Expansion

During the quarter, the company continued expanding its hub-and-spoke network across core and emerging geographies.

In April 2026, Vijaya Diagnostic commissioned a hub centre in Gachibowli, Hyderabad, equipped with a 160-slice cardiac CT scanner. Subsequently, in July 2026, the company launched a flagship hub centre in JP Nagar, Bengaluru. The Bengaluru unit features digital PET-CT with built-in cardiac CT and a 75cm wide bore 3T Omega MRI—the first system of its kind installed in Karnataka. Additionally, four new spoke units were commissioned across Hyderabad, Andhra Pradesh, and Pune during Q1 FY27.

Official Sources

According to official regulatory disclosures filed with the National Stock Exchange of India Limited and BSE Limited, the company submitted its unaudited financial results and press release following board approval on August 6, 2026.

Executive Commentary

"I'm pleased to start on a positive note, as we delivered a strong year-on-year revenue growth of approximately 22.8%, supported by volume growth of nearly 16.5% in Q1 FY27," said Suprita Reddy, Managing Director and Chief Executive Officer of Vijaya Diagnostic Centre Limited. "Revenues also surpassed Q4 FY26 in absolute terms, which is notable given that Q1 is typically a moderate season for the diagnostic industry."

Reddy added: "As we expand our footprint across our core geographies, West Bengal, Karnataka, and Pune, we remain focused on building a stronger technical and mid-to-senior leadership team to enable disciplined execution and sustainable scaling of the business."

Impact on Healthcare Consumers and Market Investors

For patients, the ongoing introduction of advanced imaging infrastructure—including wide-bore MRIs and high-slice cardiac CT scanners—enhances diagnostic accessibility and scan speeds. For equity investors, the double-digit footprint growth, combined with margin expansion and an debt-free capital profile, highlights consistent execution across primary and tier-2 markets in India.

Key Facts at a Glance

Consolidated Revenue: INR 2,309.8 million (2.31 billion rupees), up 22.8% YoY.
Consolidated PAT: INR 531.0 million (531 million rupees), up 37.6% YoY.
EBITDA Margin: 42.7%, expanding 356 bps YoY.
Total Test Volumes: 4.59 million completed tests.
Operational Network: 160+ diagnostic centres and 27 reference laboratories across 27 cities.

Frequently Asked Questions

What was Vijaya Diagnostic Centre's net profit in Q1 FY27? Vijaya Diagnostic Centre reported a consolidated profit after tax (PAT) of 531 million rupees (INR 53.10 crore) for Q1 FY27, representing a 37.6% increase year-on-year.

How much revenue did Vijaya Diagnostic Centre generate in Q1 FY27? The company posted consolidated revenue from operations of 2.31 billion rupees (INR 2,309.8 million), registering a 22.8% growth compared to Q1 FY26.

What key operational expansions were undertaken recently? Vijaya Diagnostic opened hub centres in Gachibowli (Hyderabad) and JP Nagar (Bengaluru), along with four spoke locations across Hyderabad, Andhra Pradesh, and Pune during Q1 FY27.